Hospitals.net
Explore
FollowingSign In

Hospitals.net

The network behind healthcare.

Directory

  • Explore
  • Hospitals
  • Clinics
  • For professionals

Resources

  • Conditions
  • Medications
  • Supplements
  • Health resources
  • Medical procedures
  • Online care

Company

  • About
  • Contact
  • Privacy
  • Terms
  • Disclaimer

© 2026 Hospitals.net

United States/Canada
Dupixent - Drug Information

Dupixent

📚Health Resources
🔎Find Hospitals NearbyFind Hospitals📷Images

Drug Class

IL-4 receptor alpha antagonist

Type

brand

Active Ingredient

dupilumab

Educational overview only. This page summarizes publicly available information about Dupixent for general understanding. For full prescribing details, consult official labeling or a healthcare professional.

📋Overview

Dupixent is a laboratory-made protein known as a monoclonal antibody. It works by targeting and blocking the action of specific natural substances in the body that contribute to inflammation.

By interfering with these pathways, the medication helps to manage conditions where the immune system is overactive. This treatment is designed to address the underlying inflammatory processes.

Share

📚References

Dupilumab Injection

Information from MedlinePlus.gov (NIH).

Found an Error?

Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.

Find Discounts for Dupixent

Hospitals.net Disclosure

Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.

Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.